AGP
PRAX icon

Artia Global Partners’s Praxis Precision Medicines PRAX Stock Holding History

Artia Global Partners’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$805K Hold
2,500
– – 0.16% 44
2025
Q4 		$737K Buy
+2,500
New +$466K 0.1% 51

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Artia Global Partners's PRAX Position: Q1 2026 in Review

Artia Global Partners held its Praxis Precision Medicines (PRAX) position steady in Q1 2026 at 2,500 shares worth $805K. The position accounts for 0.16% of the portfolio, ranked #44.

Artia Global Partners first reported a position in PRAX in Q4 2025 and has held it in 2 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Artia Global Partners held 2,500 shares of Praxis Precision Medicines worth $805K as of Q1 2026.
  • Artia Global Partners left its Praxis Precision Medicines share count unchanged in Q1 2026.
  • Praxis Precision Medicines made up 0.16% of Artia Global Partners's portfolio in Q1 2026, its #44 holding.
  • Artia Global Partners first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 2 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.